Kumagaya General Hospital

Kumagaya-shi, Saitama 360-8567

0 studies enrolling now · 4 studies all time

What they study most

Ulcerative Colitis

Studies at this site

• ABTECT - Maintenance — Running, not enrolling
• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2 — Completed
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed